Neoplasms, Plasma Cell
Showing 1 - 25 of >10,000
Multiple Myeloma, Primary Plasma Cell Leukemia Trial in Shanghai (Experimental: CAR-T cells Infusion)
Not yet recruiting
- Multiple Myeloma
- Primary Plasma Cell Leukemia
- Experimental: CAR-T cells Infusion
-
Shanghai, ChinaShanghai Changzheng Hospital
Apr 20, 2023
Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial (CAR-T (CAR-GPRC5D))
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
- Plasma Cell Leukemia
- CAR-T (CAR-GPRC5D)
- (no location specified)
Feb 26, 2023
Multiple Myeloma, Plasma Cell Leukemia Trial in Suzhou (CT0594CP)
Recruiting
- Multiple Myeloma
- Plasma Cell Leukemia
- CT0594CP
-
Suzhou, Jiangsu, ChinaFirst Affiliated Hospital, Soochow University
Apr 18, 2023
Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial in Wuhan (CAR-T (CAR-GPRC5D))
Recruiting
- Relapsed/Refractory Multiple Myeloma
- Plasma Cell Leukemia
- CAR-T (CAR-GPRC5D)
-
Wuhan, Hu Bei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
May 17, 2022
Multiple Myeloma, Plasma Cell Tumor, Malignant Plasma Cell Tumor Trial in Houston (Radiation Therapy)
Recruiting
- Multiple Myeloma
- +2 more
- Radiation Therapy
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2022
Plasma Cell Tumor Trial in Atlanta (Pneumococcal 13-valent Conjugate Vaccine, Trivalent Influenza Vaccine)
Active, not recruiting
- Plasma Cell Neoplasm
- Pneumococcal 13-valent Conjugate Vaccine
- Trivalent Influenza Vaccine
-
Atlanta, Georgia
- +1 more
Jan 24, 2022
A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH
Recruiting
- Multiple Myeloma
- +11 more
- No intervention
-
Beijing, ChinaPeking University First Hospital
Apr 21, 2022
Multiple Myeloma, Fatigue, Pain Trial (Auricular Acupuncture)
Not yet recruiting
- Multiple Myeloma
- +3 more
- Auricular Acupuncture
- (no location specified)
Mar 7, 2023
Multiple Myeloma Trial in Wuhan (Plasma-free procedure)
Completed
- Multiple Myeloma
- Plasma-free procedure
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Feb 10, 2022
Relapsed/Refractory Multiple Myeloma Trial in Philadelphia (Cevostamab)
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Apr 7, 2023
Lymphoma, Leukemia, Plasma Cell Dyscrasia Trial in San Francisco (Web Application)
Not yet recruiting
- Lymphoma
- +2 more
- Web Application
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 4, 2022
Tumor, Plasma Cell, Lymphoma Trial in Toulouse (Comprehensive Geriatric Assessment)
Recruiting
- Neoplasm, Plasma Cell
- Lymphoma
- Comprehensive Geriatric Assessment
-
Toulouse, FranceUniversity Hospital Toulouse
Oct 12, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Capivasertib)
Active, not recruiting
- Advanced Lymphoma
- +5 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jun 28, 2022
Examination of Trends in Multiple Myeloma Trial Patient
Not yet recruiting
- Multiple Myeloma
- (no location specified)
May 19, 2023
Immunophenotyping of Plasma Cells and Immune Effector Cells in
Not yet recruiting
- Multiple Myeloma
- Biological sampling
- (no location specified)
Jun 17, 2022
Non-Hodgkin's Lymphoma, Plasma Cell Myeloma Trial in Philadelphia (procedure, drug, other)
Completed
- Non-Hodgkin's Lymphoma
- Plasma Cell Myeloma
- Hematopoietic Cell Transplantation
- +2 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Nov 16, 2022
Learn How Triple Class Refractory Multiple Myeloma Are Treated
Not yet recruiting
- Relapse Multiple Myeloma
- Refractory Multiple Myeloma
- (no location specified)
Feb 15, 2023
Based on Maintenance Therapy Post Autologous Stem Cell
Recruiting
- Multiple Myeloma
- Autologous Stem Cell Transplant
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Jul 27, 2022
Multiple Myeloma, Amyloidosis, Cryoglobulinemia Trial in Chapel Hill
Recruiting
- Multiple Myeloma
- +8 more
-
Chapel Hill, North CarolinaNorth Carolina Cancer Hospital
Nov 30, 2021
ctDNA Methylation Sequencing for Myeloma
Recruiting
- Multiple Myeloma
- plasma circulation DNA methylation sequencing
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital Chinese Acad
Oct 11, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Trametinib
Active, not recruiting
- Advanced Lymphoma
- +5 more
- Trametinib Dimethyl Sulfoxide
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Aug 13, 2022
Multiple Myeloma Trial in Houston (Belantamab mafodotin)
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
-
Houston, TexasM D Anderson Cancer Center
Jan 5, 2023
Lymphoid Leukemia, Acute, Myeloid Malignancy, Plasma Cell Tumor Trial in Miami (T-cell Receptor a/ß Depleted Donor Lymphocyte
Recruiting
- Lymphoid Leukemia, Acute
- +2 more
- T-cell Receptor α/β Depleted Donor Lymphocyte Infusions
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc
May 24, 2022
Chemo-induced Peripheral Neuropathy, Plasma Cell Myeloma Trial in Winston-Salem (VascuTherm5 vascular compression device)
Recruiting
- Chemotherapy-induced Peripheral Neuropathy
- Plasma Cell Myeloma
- VascuTherm5 vascular compression device
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Dec 16, 2022
Myeloma Multiple, Lymphoma Trial in Maastricht (Vitamin C, Placebos)
Completed
- Myeloma Multiple
- Lymphoma
- Vitamin C
- Placebos
-
Maastricht, Limburg, NetherlandsMUMC+
Apr 19, 2022